Verition Fund Management LLC Sarepta Therapeutics, Inc. Transaction History

Verition Fund Management LLC

$13 Billion
Q1 2024

A detailed history of Verition Fund Management LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 5,430 shares of SRPT stock, worth $857,940. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,430

Previous 3,534 53.65%

Holding current value

$857,940

Previous $340,000 106.47%

% of portfolio

0.01%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$93.7 - $141.53 $177,655 - $268,340	1,896 Added 53.65%	5,430 $702,000
Q4 2023 Feb 14, 2024	BUY	$67.31 - $124.76 $46,982 - $87,082	698 Added 24.61%	3,534 $340,000
Q3 2023 Nov 14, 2023	SELL	$102.5 - $123.59 $3.71 Million - $4.47 Million	-36,200 Reduced 92.73%	2,836 $343,000
Q2 2023 Aug 14, 2023	BUY	$106.4 - $157.19 $3.51 Million - $5.18 Million	32,976 Added 544.16%	39,036 $4.47 Million
Q1 2023 May 15, 2023	SELL	$117.53 - $155.99 $181,348 - $240,692	-1,543 Reduced 20.29%	6,060 $835,000

Q4 2022 Feb 14, 2023	BUY	$100.86 - $132.13 $337,477 - $442,106	3,346 Added 78.6%	7,603 $985,000
Q3 2022 Nov 14, 2022	BUY	$75.71 - $119.24 $322,297 - $507,604	4,257 New	4,257 $471,000
Q3 2021 Nov 15, 2021	SELL	$65.97 - $92.48 $301,153 - $422,171	-4,565 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$69.38 - $86.75 $485 - $607	-7 Reduced 0.15%	4,565 $355,000
Q1 2021 May 18, 2021	BUY	$72.25 - $168.95 $79,186 - $185,169	1,096 Added 31.53%	4,572 $340,000
Q3 2020 Nov 16, 2020	BUY	$127.12 - $172.34 $441,869 - $599,053	3,476 New	3,476 $488,000
Q1 2020 May 15, 2020	SELL	$82.38 - $131.64 $476,074 - $760,747	-5,779 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$76.53 - $135.58 $442,266 - $783,516	5,779 New	5,779 $746,000
Q2 2019 Aug 14, 2019	SELL	$112.21 - $151.95 $839,555 - $1.14 Million	-7,482 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$106.67 - $151.68 $798,104 - $1.13 Million	7,482 New	7,482 $892,000
Q4 2018 Feb 14, 2019	SELL	$97.32 - $148.76 $646,788 - $988,658	-6,646 Closed	0 $0
Q3 2018 Nov 15, 2018	BUY	$115.31 - $161.51 $404,276 - $566,254	3,506 Added 111.66%	6,646 $1.07 Million
Q2 2018 Aug 15, 2018	BUY	$71.74 - $153.69 $225,263 - $482,586	3,140 New	3,140 $415,000

Others Institutions Holding SRPT

# of Institutions

470

Shares Held

79.3M

Call Options Held

4.23M

Put Options Held

1.21M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $13.8B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Account

Verition Fund Management LLC Sarepta Therapeutics, Inc. Transaction History